| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |